Clinical Trial Update

Category
Continent
From
To
 
FDA Grants Priority Review to Sanofi's Tolebrutini...

FDA Grants Priority Review to Sanofi's Tolebrutini...

Category : Clinical Trial Update 26 March 2025

The US Food and Drug Administration (FDA) is evaluating under priority review the regulatory submiss...
Clearmind’s FDA-Approved CMND-100 Trial Moves Forw...

Clearmind’s FDA-Approved CMND-100 Trial Moves Forw...

Category : Clinical Trial Update 26 March 2025

Clearmind Medicine Inc, a clinical-stage biotech company focused on discovery and development of nov...
Tempero Bio Starts Phase 2 Trial with TMP-301 for...

Tempero Bio Starts Phase 2 Trial with TMP-301 for...

Category : Clinical Trial Update 25 March 2025

Nxera Pharma Co., Ltd. announces that its partner Tempero Bio, Inc. has initiated a Phase 2 trial of...
Pharming Doses First Patient in Phase II Trial of...

Pharming Doses First Patient in Phase II Trial of...

Category : Clinical Trial Update 24 March 2025

Pharming Group NV, a global biopharmaceutical company dedicated to transforming the lives of patient...
FRUSICA-2 Trial Meets Primary Endpoint for RCC in...

FRUSICA-2 Trial Meets Primary Endpoint for RCC in...

Category : Clinical Trial Update 20 March 2025

Innovent Biologics, Inc, a world-class biopharmaceutical company that develops, manufactures and com...

Categories

Latest Newsletter Post

Subscribe to Our Newsletter!

Subscribe to get latest updates and information.

Welcome Back Sign in to Continue

Don't Have an Account? Sign Up!
Forgot Password?

Create your Account!